Frazier Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$138K Buy
150
+65
+76% +$65.9K 0.08% 94
2025
Q4
$91.4K Sell
85
-140
-62% -$134K 0.05% 116
2025
Q3
$172K Sell
225
-33
-13% -$24.6K 0.11% 70
2025
Q2
$201K Sell
258
-59
-19% -$45.8K 0.14% 56
2025
Q1
$262K Sell
317
-204
-39% -$170K 0.2% 44
2024
Q4
$403K Sell
521
-32
-6% -$26.5K 0.32% 33
2024
Q3
$490K Buy
553
+34
+7% +$30.6K 0.38% 29
2024
Q2
$470K Sell
519
-46
-8% -$36.8K 0.37% 32
2024
Q1
$439K Buy
565
+155
+38% +$110K 0.36% 32
2023
Q4
$239K Buy
+410
New +$239K 0.21% 43

Other funds holding LLY

Frazier Financial Advisors's LLY Position: Q1 2026 in Review

Frazier Financial Advisors increased its Eli Lilly (LLY) stake by 76% in Q1 2026, buying an estimated $65.9K and bringing the position to 150 shares worth $138K. The position accounts for 0.08% of the portfolio, ranked #94.

Frazier Financial Advisors first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $490K in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Frazier Financial Advisors held 150 shares of Eli Lilly worth $138K as of Q1 2026.
  • Frazier Financial Advisors bought 65 Eli Lilly shares in Q1 2026, an estimated $65.9K.
  • Eli Lilly made up 0.08% of Frazier Financial Advisors's portfolio in Q1 2026, its #94 holding.
  • Frazier Financial Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Frazier Financial Advisors's Eli Lilly position peaked at $490K in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Frazier Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.